Perceptive Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Perceptive Advisors’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,708,705	Closed	-$104M	–	136
2019 Q3	$104M	Buy	3,708,705 +155,645	+4%	+$2.52M	2.79%	10
2019 Q2	$50.1M	Buy	3,553,060 +427,209	+14%	+$4.06M	1.15%	21
2019 Q1	$27.8M	Hold	3,125,851	–	–	0.78%	33
2018 Q4	$23.7M	Hold	3,125,851	–	–	0.9%	31
2018 Q3	$65.5M	Hold	3,125,851	–	–	1.75%	16
2018 Q2	$93.5M	Buy	3,125,851 +344,874	+12%	+$9.39M	2.45%	9
2018 Q1	$75.4M	Buy	2,780,977 +971,962	+54%	+$29.1M	2.11%	11
2017 Q4	$52.1M	Buy	1,809,015 +55,000	+3%	+$1.51M	1.73%	15
2017 Q3	$42.6M	Buy	1,754,015 +47,516	+3%	+$1.13M	1.63%	14
2017 Q2	$38M	Buy	+1,706,499	New	+$35.9M	1.91%	13

Perceptive Advisors's DOVA Position: Q4 2019 in Review

Perceptive Advisors sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 3,708,705 shares — an estimated $104M sold.

Perceptive Advisors first reported a position in DOVA in Q2 2017 and held it in 10 quarters. The position peaked at $104M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Perceptive Advisors reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Perceptive Advisors sold 3,708,705 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $104M.
Perceptive Advisors first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Perceptive Advisors's Dova Pharmaceuticals, Inc. Common Stock position peaked at $104M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.